Woda
Alain Woda, Ceyrat FR
Patent application number | Description | Published |
---|---|---|
20140272875 | APPLIANCE FOR SIMULATING THE CHEWING ACTION OF A MAMMAL - The invention relates to an appliance for simulating the chewing action of a mammal, said appliance comprising two elements ( | 09-18-2014 |
Johannes Woda, Walldorf DE
Patent application number | Description | Published |
---|---|---|
20140282880 | System and Method for Common On-Behalf Authorization Protocol Infrastructure - A centralized authorization client, in a secure system, that references service provider specific on-behalf authorization protocol implementation records for generating access request messages for accessing user resources hosted by multiple service providers, is disclosed. The service provider-specific authorization implementation records include parameters for requesting user resources associated with a requesting user provided by a specific service provider. Applications running in the secure system can send access request messages through the authorization client to obtain authorization or access to user resources in multiple external service providers so the resources can be displayed, or otherwise manipulated, from application within the secure system. Once authorization is obtained for accessing the resources, the authorization client can store authorization tokens for use in persistent authorized access to multiple external service providers for resources owned by particular users. | 09-18-2014 |
Juliana Megan Woda, Shaker Heights, OH US
Patent application number | Description | Published |
---|---|---|
20110020293 | Use of Stem Cells to Reduce Leukocyte Extravasation - The invention is generally directed to reducing inflammation by means of cells that secrete factors that reduce leukocyte extravasation. Specifically, the invention is directed to methods using cells that secrete factors that downregulate the expression of cellular adhesion molecules in vascular endothelial cells. Downregulating expression of cellular adhesion molecules reduces leukocyte adhesion to the endothelial cells such that extravasation is reduced. The end result is a reduction of inflammation. The cells are non-embryonic non-germ cells that have pluripotent characteristics. These may include expression of pluripotential markers and broad differentiation potential. | 01-27-2011 |
20110206647 | Modulation of Angiogenesis - The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors. | 08-25-2011 |
20140037596 | Use of Stem Cells to Reduce Leukocyte Extravasation - The invention is generally directed to reducing inflammation by means of cells that secrete factors that reduce leukocyte extravasation. Specifically, the invention is directed to methods using cells that secrete factors that downregulate the expression of cellular adhesion molecules in vascular endothelial cells. Downregulating expression of cellular adhesion molecules reduces leukocyte adhesion to the endothelial cells such that extravasation is reduced. The end result is a reduction of inflammation. The cells are non-embryonic non-germ cells that have pluripotent characteristics. These may include expression of pluripotential markers and broad differentiation potential. | 02-06-2014 |
20140242629 | Modulation of Angiogenesis - The invention provides methods for treating pathological conditions that can be improved by providing angiogenesis. The invention is generally directed to provide angiogenesis by administering cells that express and/or secrete one or more pro-angiogenic factors. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to express and/or secrete one or more pro-angiogenic factors. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired levels of expression and/or secretion of one or more pro-angiogenic factors. | 08-28-2014 |
Patrick Woda, Wien AT
Patent application number | Description | Published |
---|---|---|
20110263567 | COMPOUNDS FOR INHIBITING SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) / VASCULAR ADHESION PROTEIN-1 (VAP-1) AND USES THEREOF FOR TREATMENT AND PREVENTION OF DISEASES - The present invention relates to compounds of general formula (i) having an oxime moiety or a pharmaceutically acceptable salt, hydrate or solvate thereof and its use for inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1), a pharmaceutical composition comprising the compound or a salt, hydrate or solvate thereof as an active ingredient, a method for the prevention or the treatment of a SSAO/VAP-1 related disease, said diseases including acute or chronic inflammatory diseases, diseases related to carbohydrate metabolism, diabetes-associated complications, diabetic retinopathy and macular oedema, diseases related to adipocyte or smooth muscle dysfunctions, neurodegenerative diseases and vascular diseases. | 10-27-2011 |
Robert Raymond Woda, Danville, KY US
Patent application number | Description | Published |
---|---|---|
20130031697 | Ortho-sweatband head restraint for adjustable headrests - The sweatband head support's unique features: Being designed specifically to be attached to almost any adjustable headrest without the need with any extra or special accessories. It allows effortless freedom of movement within normal range, while still providing adequate support and complete comfort even with long periods of wear by the user. If attached to a wheelchair, encountering rough terrain, the head can still comfortably maintain a correct upright position on its own. Regardless of the activity the user can remain focused for longer periods of time without compromising comfort, therefore giving the user a better quality of life. The sweatband portion's soft fabric covering can be provided in an assortment of colors or patterns, making it even more personalized for the user. It has the stylish appearance of a regular sweatband, so it does not appear like a support device. | 02-07-2013 |